心宝丸治疗心血瘀阻型心绞痛临床观察  

Heart treasure pill in the treatment of blood stasis resistance type angina pectoris clinical observation

作　　者：熊晓玲[1] 陈胜男[1] 洪勇[2] 孟繁烨[1] 张云飞[1] 李建君[1] 李兴鹏[1] 彭兰[1] 

机构地区：[1]四川省中西医结合医院,四川成都610041 [2]彭州市人民医院,四川彭州611900

出　　处：《四川中医》2014年第12期164-165,共2页Journal of Sichuan of Traditional Chinese Medicine

摘　　要：目的:观察心宝丸治疗心血瘀阻型心绞痛的疗效。方法:全部病例均为我院住院患者,参照WHO冠心病诊断标准选择有典型心绞痛反复发作,常规心电图有典型缺血性ST—T改变者并且属中医心血瘀阻型心绞痛患者76例,随机分为心宝丸治疗组(治疗组)和单纯西医治疗组(对照组)。结果:治疗组心绞痛疗效总有效率87.5%,心电图改变总有效率为85.70%与对照组比较差异显著(P<0.01)。结论:心宝丸治疗冠心痛心绞痛(心血瘀阻型)疗效肯定,安全性高、副反应小。Objective： To observe the XinBao pill therapy blood stagnation angina. Methods： All eases were hospital patients, according to WHO diagnostic criteria for selection of coronary heart disease with typical recurrent angina, typical ischemic ECG ST-T changes were traditional Chinese medicine blood stagnation and angina patients 76cases were randomly divided XinBao pill for heart treatment group （the treatment group） and western medicine treatment （control group）. Results： The total effective rate angina 87. 5% , ECG changes effective rate of 85. 70% of the total compared with control group were significantly different （ P〈0. 01 ）. Conclusion： Treatment of coronary XinBao pill angina （ blood stagnation type） is effective, safe, fewer side effects.

关 键 词：心宝丸 心血瘀阻 心绞痛 

分 类 号：R541.4[医药卫生—心血管疾病]